Save up to 30% on The Business Research Company’s comprehensive market research reports for a limited time only!

What Will Be the Growth Trajectory of the Anti-Vascular Endothelial Growth Factor Therapeutics Market from 2024 to 2033?

The market size of anti-vascular endothelial growth factor therapeutics has seen a slight growth in recent times. It is projected to expand from $12.18 billion in 2023 to $12.35 billion in 2024, demonstrating a compound annual growth rate (CAGR) of 1.3%. The growth witnessed in the historic period is due to increased instances of age-related macular degeneration, a surge in diabetic retinopathy incidents, progress in diagnosing retinal disease, success and effectiveness in clinical trials, and a transition to outpatient care.

The market for anti-vascular endothelial growth factor therapeutics is anticipated to experience a slight expansion in the upcoming years, with its value projected to reach $13.13 billion in 2028, growing at a compound annual growth rate (CAGR) of 1.5%. The projected growth during the forecast period can be associated with factors such as an aging population and prevalence of ocular diseases, broadening use in retinal disorders, advancement of new-generation therapeutics, an increased focus on early intervention, worldwide health initiatives, and improved access to treatment. Key emerging trends during the forecast period involve their growing use in cancer therapy, emphasis on combined treatments in ophthalmology, investigation of biosimilar versions, studies on resistance mechanisms, and incorporation with imaging technologies.

Claim Your Free Sample of the Global Anti-Vascular Endothelial Growth Factor Therapeutics Market Report Today!

https://www.thebusinessresearchcompany.com/sample.aspx?id=10683&type=smp

What Are the Primary Growth Drivers for the anti-vascular endothelial growth factor therapeutics Market?

The rise in cases of eye diseases is predicted to spark the expansion of the anti-vascular endothelial growth factor therapeutics market. The term “prevalence of ophthalmic diseases” refers to the rate or percentage of individuals in a certain population that show or have been diagnosed with specific eye disorders. Anti-vascular endothelial growth factor (VEGF) therapies can lower disease prevalence by effectively treating conditions such as wet age-related macular degeneration (AMD), diabetic retinopathy, and retinal vein occlusion. For example, World Health Organization data from October 2022 shows that around 2.2 billion people worldwide have impaired vision for close-up or distant objects, and 1 billion suffer from such impairment. Of these, 88.4 million struggle with refractive error, 94 million have cataracts, 8 million suffer from age-related macular degeneration, and approximately 3.9 million are affected by diabetic retinopathy. Consequently, the rise in the incidence of eye diseases is fueling the expansion of the anti-vascular endothelial growth factor therapeutics market.

What Are the Defining Segments of the Anti-Vascular Endothelial Growth Factor Therapeutics Market?

1) By Product: Eylea, Lucentis, Beovu

2) By Disease: Macular Edema, Diabetic Retinopathy, Retinal Vein Occlusion, Age-related Macular Degeneration

3) By End Users: Hospitals, Clinics, Oncology Centers, Other End Users

What Trends Are Revolutionizing Standards in the Anti-Vascular Endothelial Growth Factor Therapeutics Market?

The emergence of advanced treatments is a rising trend in the anti-vascular endothelial growth factor therapeutics sector. Businesses engaged in this market are leveraging these innovative therapies to stay competitive. For instance, Ashvattha Therapeutics Inc, an American clinical-stage biopharmaceutical firm, revealed safety data in May 2022 for phase 1 for healthy subjects concerning subcutaneous anti-VEGF for age-related macular degeneration and diabetic macular edema candidates. The D-4517.2 therapy, which is a pioneering therapy designed to fulfill the unmet requirements of diabetic macular edema conditions, is under development for self-administration via an autoinjector. This autoinjector – D-4517.2, gives patients the convenience to self-administer the treatment monthly at home.

Order Now for Fast Delivery of Your Anti-Vascular Endothelial Growth Factor Therapeutics Market Report!

https://www.thebusinessresearchcompany.com/report/anti-vascular-endothelial-growth-factor-therapeutics-global-market-report

What Regions Are Propelling Growth in the Anti-Vascular Endothelial Growth Factor Therapeutics Industry?

North America was the largest region in the anti-vascular endothelial growth factor therapeutics market in 2023. Europe is expected to be the fastest-growing region in the global anti-vascular endothelial growth factor therapeutics market report during the forecast period. The regions covered in the anti-vascular endothelial growth factor therapeutics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The Anti-Vascular Endothelial Growth Factor Therapeutics Global Market Report 2024 offers a comprehensive overview of the audio equipment market, covering historical data from 2010 to 2021 and providing a ten-year forecast from 2023 to 2032. This report examines the size of the anti-vascular endothelial growth factor therapeutics market, its market share, and analyzes key competitors along with their market positions.

The Table Of Content For The Anti-Vascular Endothelial Growth Factor Therapeutics Market Include

1. Anti-Vascular Endothelial Growth Factor Therapeutics Market Executive Summary

2. Anti-Vascular Endothelial Growth Factor Therapeutics Market Segments

3. Anti-Vascular Endothelial Growth Factor Therapeutics Market Size And Template Market Growth Rate

4. Key Anti-Vascular Endothelial Growth Factor Therapeutics Market Trends

5. Major Anti-Vascular Endothelial Growth Factor Therapeutics Market Drivers

……

25. Key Mergers And Acquisitions In The Anti-Vascular Endothelial Growth Factor Therapeutics Market

26. Top Anti-Vascular Endothelial Growth Factor Therapeutics Companies

27. Anti-Vascular Endothelial Growth Factor Therapeutics Market Opportunities And Strategies

28. Anti-Vascular Endothelial Growth Factor Therapeutics Market, Conclusions And Recommendations

29. Appendix

Discover Related Reports by The Business Research Company:

Antivirals Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/antivirals-global-market-report

Hematology Drugs Global Market Report 2022

https://www.thebusinessresearchcompany.com/report/hematology-drug-global-market-report

Anti-Hypertensive Drugs Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/anti-hypertensive-drugs-global-market-report

Learn More About The Business Research Company

The Business Research Company has published over 15000+ reports in 27 industries, spanning 60+ geographies. The reports draw on 1,500,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at [email protected]

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: